Skip to main content
. 2011 Sep 12;16(9):407–410. doi: 10.1186/2047-783X-16-9-407

Figure 1.

Figure 1

Time course of AQLQ for patients with asthma alone (red) and concomitant atopic dermatitis and asthma (blue). AQLQ was improved in the asthma alone group after 6 months omalizumab treatment (P < 0.05: 2 months, 3 months, 6 months and 12 months vs. baseline), while no significant change was seen in AQLQ in the atopic dermatitis/asthma group.

HHS Vulnerability Disclosure